grant
CORE C: CLINICAL AND BIOSTATISTICS CORE
NIHUS FederalResearch GrantFY2025AgingBMCELLTYBiometricsBiometryBiostatisticsBiostatistics CoreBlood Plasma CellBody TissuesBone Marrow AspirationBone Marrow CellularityCOVID-19COVID-19 immunityCV-19Cancer CenterCharacteristicsClinicClinicalClinical Practice GuidelineClinical ProtocolsClinical ResearchClinical StudyCollaborationsCommunicable DiseasesCoronavirus Infectious Disease 2019DataData CollectionData SetData Storage and RetrievalDevelopmentEnrollmentEnsureFNAFine Needle AspirateFine needle aspiration biopsyFine-Needle AspirationFutureGCP standardGoalsGood Clinical PracticeGrantHCoVHealthHumanImmuneImmune memoryImmune responseImmunesImmunityImmunochemical ImmunologicImmunologicImmunologic MemoryImmunologicalImmunological MemoryImmunologicallyImmunologicsImmunology procedureInfectionInfectious DiseasesInfectious DisorderInnate ImmunityInstitutionInvestigatorsKnowledgeLong COVIDLong COVID-19Long coronavirus diseaseLong coronavirus disease 2019Long-term Follow-upLong-term cohortLongitudinal cohortLymph Node Reticuloendothelial SystemLymph node properLymphatic nodesMeasuresMethodsModelingModern ManMonitorMucosaMucosal TissueMucous MembraneNative ImmunityNatural ImmunityNon-Specific ImmunityNonspecific ImmunityParameter EstimationParticipantPatientsPhasePlasma CellsPlasmacytesProceduresPublic HealthRegulatory approvalReproducibilityResearchResearch DesignResearch PersonnelResearch SpecimenResearch SupportResearchersSARS-CoV-2 immunitySamplingSevere acute respiratory syndrome coronavirus 2 immunitySeverity of illnessSiteSpecimenStatistical Data AnalysesStatistical Data AnalysisStatistical Data InterpretationStudy TypeSymptomsTissuesUniversitiesVaccinationVaccinesViraladaptive immunityage groupagedanalyzing longitudinalanamnestic reactionbiological specimen archivesbiosample archivebiospecimen archivechronic COVIDchronic COVID-19chronic novel coronavirus disease 2019clinical infrastructureclinical practice and guidelinescohortcomplex datacoronavirus disease 2019coronavirus disease 2019 immunitycoronavirus disease-19coronavirus infectious disease-19data managementdata retrievaldata sharingdata storagedevelopmentaldisease severityenrollexperiencehost responsehuman CoVhuman corona virushuman coronavirusimmune senescenceimmune system responseimmunity against COVID-19immunity against SARS-CoV-2immunity against Severe acute respiratory syndrome coronavirus 2immunity against coronavirus disease 2019immunity to COVID-19immunity to SARS-CoV-2immunity to Severe acute respiratory syndrome coronavirus 2immunity to coronavirus disease 2019immunologic assayimmunologic assay/testimmunoresponseimmunosenescenceimprovedinsightinterestlong haul COVIDlong haul COVID-19long haul coronavirus diseaselong haul coronavirus disease 2019long-hauler COVIDlong-hauler COVID-19long-hauler coronavirus disease 2019long-hauler syndromelong-term COVIDlong-term COVID-19long-term coronavirus diseaselong-term coronavirus disease 2019long-term followuplongitudinal analysislymph glandlymph nodeslymphnodesnovelpandemicpandemic diseaseparticipant enrollmentparticipant retentionpathogenpatient enrollmentpersistent COVID-19plasmocytepost COVID syndromepost COVID-19 syndromepost acute COVID syndromepost acute COVID-19post acute COVID-19 syndromepost acute SARS-CoV-2post acute coronavirus disease 2019post acute coronavirus disease 2019 syndromepost acute coronavirus disease syndromepost acute severe acute respiratory syndrome coronavirus 2post coronavirus disease 2019 syndromepost coronavirus disease syndromepost-acute phases of COVID-19programsprolonged COVID-19 symptomsregulatory authorizationregulatory certificationregulatory clearancesample collectionsecondary immune responseskillsspecimen archivespecimen collectionstatistical analysisstatistical analysis corestatistical corestatistics corestatistics research corestudy designsuccessvaccination studyvaccination trialvaccine studyvaccine trial
Description preview
To support the research goals of our CCHI, the Clinical and Biostatistical Core proposes to continue long-term
follow up of our established COVID-19 cohort of 747 patients over the next 5-year grant cycle. The unique
features of COVID-19 immunity can be explored in this cohort, which presents an incredible opportunity to
advance mechanistic…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click